Sept. 2005 – Dec 2008 Clinical trial of Phase III on the evaluation of Acetyl-L-carnitine (ST 200) to reduce intensity of taxane-or platinum induced sensory neuropathy. Co-principal investigator: Lévi F Multicenter (N = 24), international, randomized, 172 patients
lire la suite
Determinants of cetuximab reversal of resistance to chronomodulated chemotherapy
March 2004 – November 2006 Determinants of cetuximab reversal of resistance to chronomodulated chemotherapy as 2nd to 6th treatment line for metastatic colorectal cancer Principal investigator : Lévi F Single institution, 45 patients Lévi F., Karaboué A., Bralet M.P. et al., submitted
lire la suite
Time finding study of chronomodulated irinotecan
June 2002 – August 2005 Time finding study of chronomodulated irinotecan, 5-FU – LV and oxaliplatin as first or second chemotherapy line against metastatic colorectal cancer (EORTC 05011). Co-investigator: Lévi F Multicenter (N = 18), international, randomized, 199 patients Garufi C. et al.
lire la suite
Evaluation of fatigue and actimetry
April 2000 – Oct. 2000 Evaluation of fatigue and actimetry (AMI) Principal investigator: Lévi F Single institution, 20 patients
lire la suite